Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

Clinical trial NCT02103335 · COMPLETED

Trial details

NCT number: NCT02103335
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Refractory Multiple Myeloma Multiple Myeloma

Start date: 2014-06-05
Primary completion: 2016-10-03
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.